Preliminary results from the phase-one trial indicate promise for patient safety and positive patient outcomes.
The company expects to commence enrollment in the randomized, double-blinded, placebo-controlled trial in the fourth quarter of 2012. Interim results are expected by the end of 2013.
More Articles on Orthopedic Devices:
Globus Medical to Showcase New Spine Surgery Products
Paradigm Spine, OM HealthCare Sign Multiyear Logistics Agreement
Integra LifeSciences Launches Complete Cervical Interbody Fusion Device
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
